126 related articles for article (PubMed ID: 27881017)
1. Association between interleukin-18 variants and prostate cancer in Slovak population.
Jurecekova J; Babusikova E; Kmetova Sivonova M; Drobkova H; Petras M; Kliment J; Halasova E
Neoplasma; 2017; 64(1):148-155. PubMed ID: 27881017
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of the interleukin-18 gene and risk of prostate cancer.
Liu Y; Lin N; Huang L; Xu Q; Pang G
DNA Cell Biol; 2007 Aug; 26(8):613-8. PubMed ID: 17688413
[TBL] [Abstract][Full Text] [Related]
3. The Role of Interleukin-6 Polymorphism (rs1800795) in Prostate Cancer Development and Progression.
Jurečeková J; Drobková H; Šarlinová M; Babušíková E; Sivoňová MK; Matáková T; Kliment J; Halašová E
Anticancer Res; 2018 Jun; 38(6):3663-3667. PubMed ID: 29848725
[TBL] [Abstract][Full Text] [Related]
4. Pro-(IL-18) and Anti-(IL-10) Inflammatory Promoter Genetic Variants (Intrinsic Factors) with Tobacco Exposure (Extrinsic Factors) May Influence Susceptibility and Severity of Prostate Carcinoma: A Prospective Study.
Dwivedi S; Singh S; Goel A; Khattri S; Mandhani A; Sharma P; Misra S; Pant KK
Asian Pac J Cancer Prev; 2015; 16(8):3173-81. PubMed ID: 25921117
[TBL] [Abstract][Full Text] [Related]
5. Genetic variability at promoters of IL-18 (pro-) and IL-10 (anti-) inflammatory gene affects susceptibility and their circulating serum levels: An explorative study of prostate cancer patients in North Indian populations.
Dwivedi S; Goel A; Khattri S; Mandhani A; Sharma P; Misra S; Pant KK
Cytokine; 2015 Jul; 74(1):117-22. PubMed ID: 25892571
[TBL] [Abstract][Full Text] [Related]
6. Association between IL-18 -607 C/A Polymorphism and the Risk of Prostate Cancer: A Meta-Analysis of Case-Control Studies.
Yuanyuan G; Xue Y; Yachao L; Xiao F; Xu C
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1595-1602. PubMed ID: 31244277
[TBL] [Abstract][Full Text] [Related]
7. Effect of IL-18 gene promoter polymorphisms on prostate cancer occurrence and prognosis in Han Chinese population.
Liu JM; Liu JN; Wei MT; He YZ; Zhou Y; Song XB; Ying BW; Huang J
Genet Mol Res; 2013 Mar; 12(1):820-9. PubMed ID: 23546966
[TBL] [Abstract][Full Text] [Related]
8. The association between estrogen receptor alpha polymorphisms and the risk of prostate cancer in Slovak population.
Jurečeková J; Sivoňová MK; Evinová A; Kliment J; Dobrota D
Mol Cell Biochem; 2013 Sep; 381(1-2):201-7. PubMed ID: 23737135
[TBL] [Abstract][Full Text] [Related]
9. Association of interleukine-18 polymorphisms with susceptibility to prostate cancer in Iranian population.
Abedinzadeh M; Ghodsian M; Dastgheib SA; Jafari-Nedooshan J; Zare M; Heiranizadeh N; Raee-Ezzabadi A; Neamatzadeh H
Neoplasma; 2020 May; 67(3):644-649. PubMed ID: 32039628
[TBL] [Abstract][Full Text] [Related]
10. Association of
Sivonova MK; Jurecekova J; Kaplan P; Hives M; Grendar M; Tomascova A; Dusenka R; Drobkova H; Evin D; Kliment J
Anticancer Res; 2020 Nov; 40(11):6257-6264. PubMed ID: 33109563
[TBL] [Abstract][Full Text] [Related]
11. Genes of the interleukin-18 pathway are associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma.
Babar M; Ryan AW; Anderson LA; Segurado R; Turner G; Murray LJ; Murphy SJ; Johnston BT; Comber H; Reynolds JV; McManus R
Am J Gastroenterol; 2012 Sep; 107(9):1331-41. PubMed ID: 22664470
[TBL] [Abstract][Full Text] [Related]
12. PSCA rs1045531 Polymorphism and the Risk of Prostate Cancer in a Chinese Population Undergoing Prostate Biopsy.
Zhang X; Hu Q; Chen Y; Li M; Yin H; Zhou C; Li G; Hou J
Technol Cancer Res Treat; 2017 Dec; 16(6):1168-1172. PubMed ID: 29332451
[TBL] [Abstract][Full Text] [Related]
13. Serum concentration of interleukin-35 and its association with tumor stages and FOXP3 gene polymorphism in patients with prostate cancer.
Chatrabnous N; Ghaderi A; Ariafar A; Razeghinia MS; Nemati M; Jafarzadeh A
Cytokine; 2019 Jan; 113():221-227. PubMed ID: 30057362
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 polymorphism is associated with more aggressive prostate cancer.
Tan D; Wu X; Hou M; Lee SO; Lou W; Wang J; Janarthan B; Nallapareddy S; Trump DL; Gao AC
J Urol; 2005 Aug; 174(2):753-6. PubMed ID: 16006970
[TBL] [Abstract][Full Text] [Related]
15. The role of p21 3'UTR gene polymorphism in the risk of prostate cancer: a pilot study.
Sivoňová MK; Vilčková M; Jurečeková J; Hatok J; Dobrota D; Dušenka R; Kliment J
Mol Med Rep; 2013 Mar; 7(3):986-90. PubMed ID: 23292332
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of the cytokine-rich chromosome 5q31.1 region suggests a role for IL-4 gene variants in prostate cancer risk.
Tindall EA; Severi G; Hoang HN; Ma CS; Fernandez P; Southey MC; English DR; Hopper JL; Heyns CF; Tangye SG; Giles GG; Hayes VM;
Carcinogenesis; 2010 Oct; 31(10):1748-54. PubMed ID: 20403914
[TBL] [Abstract][Full Text] [Related]
17. Strong association of interleukin-6 -174G/C promoter single nucleotide polymorphism with a decreased risk of colorectal cancer in ethnic Kashmiri population: A case control study.
Banday MZ; Balkhi HM; Sameer AS; Chowdri NA; Haq E
Tumour Biol; 2017 Mar; 39(3):1010428317695940. PubMed ID: 28349833
[TBL] [Abstract][Full Text] [Related]
18. Association of variants in the interleukin-27 and interleukin-12 gene with nasopharyngeal carcinoma.
Wei YS; Lan Y; Luo B; Lu D; Nong HB
Mol Carcinog; 2009 Aug; 48(8):751-7. PubMed ID: 19148899
[TBL] [Abstract][Full Text] [Related]
19. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.
Onen IH; Ekmekci A; Eroglu M; Konac E; Yesil S; Biri H
Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-18 gene promoter polymorphism and the risk of nasopharyngeal carcinoma in a Chinese population.
Nong LG; Luo B; Zhang L; Nong HB
DNA Cell Biol; 2009 Oct; 28(10):507-13. PubMed ID: 19622039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
